Screening by Chest Radiograph and Lung Cancer Mortality
Martin M. Oken(Minneapolis Heart Institute Foundation), for the PLCO Project Team(University of Colorado Denver), Grant Izmirlian(National Institutes of Health), Neil Caparaso(National Institutes of Health), E. David Crawford(University of California San Diego), Philip C. Prorok(National Cancer Institute), John K. Gohagan(National Institutes of Health), Timothy R. Church(University of Minnesota), Paul F. Pinsky(National Cancer Institute), Anthony B. Miller(University of Toronto), Joel L. Weissfeld(University of Pittsburgh), Patrick Wright(Information Management Services), Claudine Isaacs(Georgetown University), Joshua M. Rathmell(National Institutes of Health), Saundra S. Buys(University of Utah), Mona N. Fouad(University of North Texas), Lance Yokochi(National Institutes of Health), Lawrence R. Ragard(Westat (United States)), Gerald L. Andriole(Institut thématique Génétique, génomique et bioinformatique), Christine D. Berg(Prevention Group), Douglas J. Reding(Ascension), Barnett S. Kramer(University of Pittsburgh), Thomas L. Riley(Automation, Information, and Management Systems (United States)), Barbara O’Brien(National Institutes of Health), Ping Hu(National Institutes of Health), Paul A. Kvale(Henry Ford Health System)
Cited by 659
Related Papers
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
|New England Journal of Medicine|1993|3.3k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
|Nature Genetics|2007|1.5k
Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
|New England Journal of Medicine|2013|1.4k